speb/financial-data huggingface dataset:
CBSM.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 218998000.00
CBSM.PA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 489000.00
CBSM.PA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 227538.00
CBSM.PA balance_sheet (quarterly, 2025-12-31) — Working Capital: 12877000.00
CBT cash_flow (annual, 2021-09-30) — Asset Impairment Charge: 0.00
CBT income_statement (annual, 2021-09-30) — Gain On Sale Of Ppe: 0.00
CBT balance_sheet (annual, 2021-09-30) — Investmentsin Associatesat Cost: 40000000.00
CBT cash_flow (annual, 2021-09-30) — Net Preferred Stock Issuance: 0.00
CBT cash_flow (annual, 2021-09-30) — Pension And Employee Benefit Expense: 5000000.00
CBT cash_flow (annual, 2021-09-30) — Preferred Stock Payments: 0.00
CBT balance_sheet (annual, 2021-09-30) — Prepaid Assets: 89000000.00
CBT cash_flow (annual, 2021-09-30) — Purchase Of Business: 0.00
CBT income_statement (annual, 2021-09-30) — Restructuring And Mergern Acquisition: 0.00
CBT income_statement (annual, 2022-09-30) — +Operating Expense: 313000000.00
CBT income_statement (annual, 2022-09-30) — +Total Revenue: 4321000000.00
CBT balance_sheet (annual, 2022-09-30) — Accounts Payable: 533000000.00
CBT balance_sheet (annual, 2022-09-30) — Accounts Receivable: 836000000.00
CBT balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -2284000000.00
CBT balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 1000000.00
CBT balance_sheet (annual, 2022-09-30) — Allowance For Doubtful Accounts Receivable: -3000000.00
CBT cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 207000000.00
CBT income_statement (annual, 2022-09-30) — Average Dilution Earnings: 0.00
CBT income_statement (annual, 2022-09-30) — Basic Average Shares: 56248559.00
CBT income_statement (annual, 2022-09-30) — Basic EPS: 3.72
CBT cash_flow (annual, 2022-09-30) — Beginning Cash Position: 170000000.00
CBT balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 553000000.00
CBT cash_flow (annual, 2022-09-30) — Capital Expenditure: -211000000.00
CBT balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 83000000.00
CBT balance_sheet (annual, 2022-09-30) — Capital Stock: 56000000.00
CBT balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 206000000.00
CBT balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 206000000.00
CBT cash_flow (annual, 2022-09-30) — Cash Dividends Paid: -84000000.00
CBT cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 145000000.00
CBT cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -118000000.00
CBT cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: 100000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Account Payable: 115000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Income Tax Payable: 15000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Inventory: -259000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Other Current Liabilities: -7000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Payable: 130000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 130000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: -25000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Receivables: -287000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Tax Payable: 15000000.00
CBT cash_flow (annual, 2022-09-30) — Change In Working Capital: -448000000.00
CBT cash_flow (annual, 2022-09-30) — Changes In Cash: 127000000.00
CBT balance_sheet (annual, 2022-09-30) — Commercial Paper: 322000000.00
CBT balance_sheet (annual, 2022-09-30) — Common Stock: 56000000.00
CBT cash_flow (annual, 2022-09-30) — Common Stock Dividend Paid: -84000000.00
CBT balance_sheet (annual, 2022-09-30) — Common Stock Equity: 898000000.00
CBT cash_flow (annual, 2022-09-30) — Common Stock Issuance: 6000000.00
CBT cash_flow (annual, 2022-09-30) — Common Stock Payments: -53000000.00
CBT balance_sheet (annual, 2022-09-30) — Construction In Progress: 224000000.00
CBT income_statement (annual, 2022-09-30) — Cost Of Revenue: 3436000000.00
CBT balance_sheet (annual, 2022-09-30) — Current Accrued Expenses: 108000000.00
CBT balance_sheet (annual, 2022-09-30) — Current Assets: 1820000000.00
CBT balance_sheet (annual, 2022-09-30) — Current Debt: 354000000.00
CBT balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 354000000.00
CBT balance_sheet (annual, 2022-09-30) — Current Liabilities: 1105000000.00
CBT cash_flow (annual, 2022-09-30) — Deferred Income Tax: -40000000.00
CBT cash_flow (annual, 2022-09-30) — Deferred Tax: -40000000.00
CBT cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 146000000.00
CBT cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 146000000.00
CBT income_statement (annual, 2022-09-30) — Diluted Average Shares: 56900000.00
CBT income_statement (annual, 2022-09-30) — Diluted EPS: 3.62
CBT income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: 206000000.00
CBT cash_flow (annual, 2022-09-30) — Dividend Received Cfo: 1000000.00
CBT income_statement (annual, 2022-09-30) — EBIT: 391000000.00
CBT income_statement (annual, 2022-09-30) — EBITDA: 537000000.00
CBT income_statement (annual, 2022-09-30) — Earnings From Equity Interest Net Of Tax: 10000000.00
CBT cash_flow (annual, 2022-09-30) — Earnings Losses From Equity Investments: -10000000.00
CBT cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: -91000000.00
CBT balance_sheet (annual, 2022-09-30) — Employee Benefits: 51000000.00
CBT cash_flow (annual, 2022-09-30) — End Cash Position: 206000000.00
CBT cash_flow (annual, 2022-09-30) — Financing Cash Flow: 145000000.00
CBT balance_sheet (annual, 2022-09-30) — Finished Goods: 427000000.00
CBT cash_flow (annual, 2022-09-30) — Free Cash Flow: -111000000.00
CBT cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of Business: 207000000.00
CBT cash_flow (annual, 2022-09-30) — Gain Loss On Sale Of PPE: -17000000.00
CBT income_statement (annual, 2022-09-30) — Gain On Sale Of Business: -207000000.00
CBT income_statement (annual, 2022-09-30) — Gain On Sale Of Ppe: 0.00
CBT balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: -439000000.00
CBT balance_sheet (annual, 2022-09-30) — Goodwill: 129000000.00
CBT balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 192000000.00
CBT balance_sheet (annual, 2022-09-30) — Gross Accounts Receivable: 839000000.00
CBT balance_sheet (annual, 2022-09-30) — Gross PPE: 3554000000.00
CBT income_statement (annual, 2022-09-30) — Gross Profit: 885000000.00
CBT cash_flow (annual, 2022-09-30) — Income Tax Paid Supplemental Data: 129000000.00
CBT balance_sheet (annual, 2022-09-30) — Income Tax Payable: 44000000.00
CBT income_statement (annual, 2022-09-30) — Interest Expense: 56000000.00
CBT income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 56000000.00
CBT income_statement (annual, 2022-09-30) — Interest Income: 11000000.00
CBT income_statement (annual, 2022-09-30) — Interest Income Non Operating: 11000000.00
CBT cash_flow (annual, 2022-09-30) — Interest Paid Supplemental Data: 46000000.00
CBT balance_sheet (annual, 2022-09-30) — Inventory: 664000000.00
CBT balance_sheet (annual, 2022-09-30) — Invested Capital: 2341000000.00
CBT cash_flow (annual, 2022-09-30) — Investing Cash Flow: -118000000.00
CBT balance_sheet (annual, 2022-09-30) — Investments And Advances: 20000000.00
CBT cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 6000000.00
CBT cash_flow (annual, 2022-09-30) — Issuance Of Debt: 670000000.00
CBT balance_sheet (annual, 2022-09-30) — Land And Improvements: 75000000.00
CBT balance_sheet (annual, 2022-09-30) — Line Of Credit: 25000000.00
CBT balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 83000000.00
CBT balance_sheet (annual, 2022-09-30) — Long Term Debt: 1089000000.00
CBT balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 1172000000.00
CBT cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 394000000.00
CBT cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -372000000.00
CBT balance_sheet (annual, 2022-09-30) — Long Term Equity Investment: 20000000.00
CBT balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 2473000000.00
CBT balance_sheet (annual, 2022-09-30) — Minority Interest: 134000000.00
CBT income_statement (annual, 2022-09-30) — Minority Interests: -34000000.00
CBT cash_flow (annual, 2022-09-30) — Net Business Purchase And Sale: 70000000.00
CBT cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: -47000000.00
CBT balance_sheet (annual, 2022-09-30) — Net Debt: 1237000000.00
CBT income_statement (annual, 2022-09-30) — Net Income: 209000000.00
CBT income_statement (annual, 2022-09-30) — Net Income Common Stockholders: 206000000.00
CBT income_statement (annual, 2022-09-30) — Net Income Continuous Operations: 243000000.00
CBT income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: 209000000.00
CBT income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: 209000000.00
CBT cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: 243000000.00
CBT income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: 243000000.00
CBT income_statement (annual, 2022-09-30) — Net Interest Income: -45000000.00
CBT cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: 298000000.00
CBT cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: 22000000.00
CBT income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: -45000000.00
CBT cash_flow (annual, 2022-09-30) — Net Other Financing Charges: -22000000.00
CBT cash_flow (annual, 2022-09-30) — Net Other Investing Changes: 5000000.00
CBT balance_sheet (annual, 2022-09-30) — Net PPE: 1270000000.00
CBT cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -193000000.00
CBT cash_flow (annual, 2022-09-30) — Net Short Term Debt Issuance: 276000000.00
CBT balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 706000000.00
CBT balance_sheet (annual, 2022-09-30) — Non Current Accrued Expenses: 100000000.00
CBT balance_sheet (annual, 2022-09-30) — Non Current Deferred Assets: 45000000.00
CBT balance_sheet (annual, 2022-09-30) — Non Current Deferred Liabilities: 65000000.00
CBT balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Assets: 45000000.00
CBT balance_sheet (annual, 2022-09-30) — Non Current Deferred Taxes Liabilities: 65000000.00
CBT income_statement (annual, 2022-09-30) — Normalized EBITDA: 720000000.00
CBT income_statement (annual, 2022-09-30) — Normalized Income: 336280597.01
CBT cash_flow (annual, 2022-09-30) — Operating Cash Flow: 100000000.00
CBT cash_flow (annual, 2022-09-30) — Operating Gains Losses: 179000000.00
CBT income_statement (annual, 2022-09-30) — Operating Income: 572000000.00
CBT income_statement (annual, 2022-09-30) — Operating Revenue: 4321000000.00
CBT balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 56248559.00
CBT balance_sheet (annual, 2022-09-30) — Other Current Assets: 114000000.00
CBT balance_sheet (annual, 2022-09-30) — Other Current Borrowings: 7000000.00
CBT balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: -439000000.00
CBT income_statement (annual, 2022-09-30) — Other Income Expense: -192000000.00
CBT balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 63000000.00
CBT balance_sheet (annual, 2022-09-30) — Other Inventories: 55000000.00
CBT cash_flow (annual, 2022-09-30) — Other Non Cash Items: -4000000.00
CBT balance_sheet (annual, 2022-09-30) — Other Non Current Assets: 178000000.00
CBT income_statement (annual, 2022-09-30) — Other Non Operating Income Expenses: -9000000.00
CBT balance_sheet (annual, 2022-09-30) — Other Properties: 229000000.00
CBT income_statement (annual, 2022-09-30) — Otherunder Preferred Stock Dividend: 3000000.00
CBT balance_sheet (annual, 2022-09-30) — Payables: 577000000.00
CBT balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 685000000.00
CBT cash_flow (annual, 2022-09-30) — Pension And Employee Benefit Expense: -1000000.00
CBT balance_sheet (annual, 2022-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 66000000.00
CBT balance_sheet (annual, 2022-09-30) — Preferred Stock: 0.00
CBT balance_sheet (annual, 2022-09-30) — Prepaid Assets: 114000000.00
CBT income_statement (annual, 2022-09-30) — Pretax Income: 335000000.00
CBT balance_sheet (annual, 2022-09-30) — Properties: 0.00
CBT cash_flow (annual, 2022-09-30) — Purchase Of Business: -9000000.00
CBT cash_flow (annual, 2022-09-30) — Purchase Of PPE: -211000000.00
CBT balance_sheet (annual, 2022-09-30) — Raw Materials: 182000000.00
CBT balance_sheet (annual, 2022-09-30) — Receivables: 836000000.00
CBT income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 3436000000.00
CBT income_statement (annual, 2022-09-30) — Reconciled Depreciation: 146000000.00
CBT cash_flow (annual, 2022-09-30) — Repayment Of Debt: -372000000.00
CBT cash_flow (annual, 2022-09-30) — Repurchase Of Capital Stock: -53000000.00
CBT income_statement (annual, 2022-09-30) — Research And Development: 55000000.00
CBT income_statement (annual, 2022-09-30) — Restructuring And Mergern Acquisition: -24000000.00
CBT balance_sheet (annual, 2022-09-30) — Retained Earnings: 1284000000.00
CBT cash_flow (annual, 2022-09-30) — Sale Of Business: 79000000.00
CBT cash_flow (annual, 2022-09-30) — Sale Of PPE: 18000000.00
CBT income_statement (annual, 2022-09-30) — Selling General And Administration: 258000000.00
CBT balance_sheet (annual, 2022-09-30) — Share Issued: 56385963.00
CBT cash_flow (annual, 2022-09-30) — Short Term Debt Issuance: 276000000.00
CBT cash_flow (annual, 2022-09-30) — Short Term Debt Payments: 0.00
CBT income_statement (annual, 2022-09-30) — Special Income Charges: -183000000.00
CBT cash_flow (annual, 2022-09-30) — Stock Based Compensation: 23000000.00
CBT balance_sheet (annual, 2022-09-30) — Stockholders Equity: 898000000.00
CBT balance_sheet (annual, 2022-09-30) — Tangible Book Value: 706000000.00
CBT income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: -55719402.99
CBT income_statement (annual, 2022-09-30) — Tax Provision: 102000000.00
CBT income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.30
CBT balance_sheet (annual, 2022-09-30) — Total Assets: 3525000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Capitalization: 1987000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Debt: 1526000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 1032000000.00
CBT income_statement (annual, 2022-09-30) — Total Expenses: 3749000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 2493000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 1705000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 1388000000.00
CBT income_statement (annual, 2022-09-30) — Total Operating Income As Reported: 389000000.00
CBT balance_sheet (annual, 2022-09-30) — Total Tax Payable: 44000000.00
CBT income_statement (annual, 2022-09-30) — Total Unusual Items: -183000000.00
CBT income_statement (annual, 2022-09-30) — Total Unusual Items Excluding Goodwill: -183000000.00
CBT balance_sheet (annual, 2022-09-30) — Treasury Shares Number: 137404.00
CBT balance_sheet (annual, 2022-09-30) — Treasury Stock: 4000000.00
CBT balance_sheet (annual, 2022-09-30) — Working Capital: 715000000.00
CBT income_statement (annual, 2023-09-30) — +Operating Expense: 310000000.00
CBT income_statement (annual, 2023-09-30) — +Total Revenue: 3931000000.00
CBT balance_sheet (annual, 2023-09-30) — Accounts Payable: 438000000.00
CBT balance_sheet (annual, 2023-09-30) — Accounts Receivable: 695000000.00
CBT balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -2415000000.00
CBT balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 0.00
CBT balance_sheet (annual, 2023-09-30) — Allowance For Doubtful Accounts Receivable: -2000000.00
CBT income_statement (annual, 2023-09-30) — Average Dilution Earnings: 0.00
CBT income_statement (annual, 2023-09-30) — Basic Average Shares: 55243804.00
CBT income_statement (annual, 2023-09-30) — Basic EPS: 8.06
CBT cash_flow (annual, 2023-09-30) — Beginning Cash Position: 206000000.00
CBT balance_sheet (annual, 2023-09-30) — Buildings And Improvements: 576000000.00
CBT cash_flow (annual, 2023-09-30) — Capital Expenditure: -244000000.00
CBT balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 84000000.00
CBT balance_sheet (annual, 2023-09-30) — Capital Stock: 55000000.00
CBT balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 238000000.00
CBT balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 238000000.00
CBT cash_flow (annual, 2023-09-30) — Cash Dividends Paid: -88000000.00
CBT cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: -403000000.00
CBT cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -214000000.00
CBT cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: 595000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Account Payable: -152000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Income Tax Payable: -4000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Inventory: 96000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Other Current Liabilities: 6000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Payable: -156000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: -156000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: 1000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Receivables: 153000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Tax Payable: -4000000.00
CBT cash_flow (annual, 2023-09-30) — Change In Working Capital: 100000000.00
CBT cash_flow (annual, 2023-09-30) — Changes In Cash: -22000000.00
CBT balance_sheet (annual, 2023-09-30) — Commercial Paper: 172000000.00
CBT balance_sheet (annual, 2023-09-30) — Common Stock: 55000000.00
CBT cash_flow (annual, 2023-09-30) — Common Stock Dividend Paid: -88000000.00
CBT balance_sheet (annual, 2023-09-30) — Common Stock Equity: 1264000000.00
CBT cash_flow (annual, 2023-09-30) — Common Stock Issuance: 4000000.00
CBT cash_flow (annual, 2023-09-30) — Common Stock Payments: -98000000.00
CBT balance_sheet (annual, 2023-09-30) — Construction In Progress: 329000000.00
CBT income_statement (annual, 2023-09-30) — Cost Of Revenue: 3092000000.00
CBT balance_sheet (annual, 2023-09-30) — Current Accrued Expenses: 107000000.00
CBT balance_sheet (annual, 2023-09-30) — Current Assets: 1626000000.00
CBT balance_sheet (annual, 2023-09-30) — Current Debt: 182000000.00
CBT balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 182000000.00
CBT balance_sheet (annual, 2023-09-30) — Current Liabilities: 822000000.00
CBT cash_flow (annual, 2023-09-30) — Deferred Income Tax: -156000000.00
CBT cash_flow (annual, 2023-09-30) — Deferred Tax: -156000000.00
CBT cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 144000000.00
CBT cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 144000000.00
CBT income_statement (annual, 2023-09-30) — Diluted Average Shares: 56500000.00
CBT income_statement (annual, 2023-09-30) — Diluted EPS: 7.73
CBT income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: 437000000.00
CBT cash_flow (annual, 2023-09-30) — Dividend Received Cfo: 2000000.00
CBT income_statement (annual, 2023-09-30) — EBIT: 541000000.00
CBT income_statement (annual, 2023-09-30) — EBITDA: 685000000.00
CBT income_statement (annual, 2023-09-30) — Earnings From Equity Interest Net Of Tax: 5000000.00
CBT cash_flow (annual, 2023-09-30) — Earnings Losses From Equity Investments: -5000000.00
CBT cash_flow (annual, 2023-09-30) — Effect Of Exchange Rate Changes: 54000000.00
CBT balance_sheet (annual, 2023-09-30) — Employee Benefits: 48000000.00
CBT cash_flow (annual, 2023-09-30) — End Cash Position: 238000000.00
CBT cash_flow (annual, 2023-09-30) — Financing Cash Flow: -403000000.00
CBT balance_sheet (annual, 2023-09-30) — Finished Goods: 374000000.00
CBT cash_flow (annual, 2023-09-30) — Free Cash Flow: 351000000.00
CBT cash_flow (annual, 2023-09-30) — Gain Loss On Sale Of Business: 3000000.00
CBT cash_flow (annual, 2023-09-30) — Gain Loss On Sale Of PPE: -1000000.00
CBT income_statement (annual, 2023-09-30) — Gain On Sale Of Business: -3000000.00
CBT balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: -362000000.00
CBT balance_sheet (annual, 2023-09-30) — Goodwill: 134000000.00
CBT balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 194000000.00
CBT balance_sheet (annual, 2023-09-30) — Gross Accounts Receivable: 697000000.00
CBT balance_sheet (annual, 2023-09-30) — Gross PPE: 3827000000.00
CBT income_statement (annual, 2023-09-30) — Gross Profit: 839000000.00
CBT cash_flow (annual, 2023-09-30) — Income Tax Paid Supplemental Data: 140000000.00
CBT balance_sheet (annual, 2023-09-30) — Income Tax Payable: 40000000.00
CBT income_statement (annual, 2023-09-30) — Interest Expense: 90000000.00
CBT income_statement (annual, 2023-09-30) — Interest Expense Non Operating: 90000000.00
CBT income_statement (annual, 2023-09-30) — Interest Income: 31000000.00
CBT income_statement (annual, 2023-09-30) — Interest Income Non Operating: 31000000.00
CBT cash_flow (annual, 2023-09-30) — Interest Paid Supplemental Data: 85000000.00
CBT balance_sheet (annual, 2023-09-30) — Inventory: 585000000.00
CBT balance_sheet (annual, 2023-09-30) — Invested Capital: 2540000000.00
CBT cash_flow (annual, 2023-09-30) — Investing Cash Flow: -214000000.00
CBT balance_sheet (annual, 2023-09-30) — Investments And Advances: 20000000.00
CBT cash_flow (annual, 2023-09-30) — Issuance Of Capital Stock: 4000000.00
CBT cash_flow (annual, 2023-09-30) — Issuance Of Debt: 108000000.00
CBT balance_sheet (annual, 2023-09-30) — Land And Improvements: 72000000.00
CBT balance_sheet (annual, 2023-09-30) — Line Of Credit: 2000000.00
CBT balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 84000000.00
CBT balance_sheet (annual, 2023-09-30) — Long Term Debt: 1094000000.00
CBT balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 1178000000.00
CBT cash_flow (annual, 2023-09-30) — Long Term Debt Issuance: 84000000.00
CBT cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -90000000.00
CBT balance_sheet (annual, 2023-09-30) — Long Term Equity Investment: 20000000.00
CBT balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 2622000000.00
CBT balance_sheet (annual, 2023-09-30) — Minority Interest: 143000000.00
CBT income_statement (annual, 2023-09-30) — Minority Interests: -39000000.00
CBT cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: 6000000.00
CBT cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: -94000000.00
CBT balance_sheet (annual, 2023-09-30) — Net Debt: 1038000000.00
CBT income_statement (annual, 2023-09-30) — Net Income: 445000000.00
CBT income_statement (annual, 2023-09-30) — Net Income Common Stockholders: 437000000.00
CBT income_statement (annual, 2023-09-30) — Net Income Continuous Operations: 484000000.00
CBT income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: 445000000.00
CBT income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: 445000000.00
CBT cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: 484000000.00
CBT income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: 484000000.00
CBT income_statement (annual, 2023-09-30) — Net Interest Income: -59000000.00
CBT cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: -179000000.00
CBT cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: -6000000.00
CBT income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: -59000000.00
CBT cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -42000000.00
CBT cash_flow (annual, 2023-09-30) — Net Other Investing Changes: 17000000.00
CBT balance_sheet (annual, 2023-09-30) — Net PPE: 1412000000.00
CBT cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -237000000.00
CBT cash_flow (annual, 2023-09-30) — Net Short Term Debt Issuance: -173000000.00
CBT balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 1070000000.00
CBT balance_sheet (annual, 2023-09-30) — Non Current Accrued Expenses: 99000000.00
CBT balance_sheet (annual, 2023-09-30) — Non Current Deferred Assets: 180000000.00
CBT balance_sheet (annual, 2023-09-30) — Non Current Deferred Liabilities: 50000000.00
CBT balance_sheet (annual, 2023-09-30) — Non Current Deferred Taxes Assets: 180000000.00
CBT balance_sheet (annual, 2023-09-30) — Non Current Deferred Taxes Liabilities: 50000000.00
CBT income_statement (annual, 2023-09-30) — Normalized EBITDA: 688000000.00
CBT income_statement (annual, 2023-09-30) — Normalized Income: 447370000.00
CBT cash_flow (annual, 2023-09-30) — Operating Cash Flow: 595000000.00
CBT cash_flow (annual, 2023-09-30) — Operating Gains Losses: -3000000.00
CBT income_statement (annual, 2023-09-30) — Operating Income: 529000000.00
CBT income_statement (annual, 2023-09-30) — Operating Revenue: 3931000000.00
CBT balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 55243804.00
CBT balance_sheet (annual, 2023-09-30) — Other Current Assets: 108000000.00
CBT balance_sheet (annual, 2023-09-30) — Other Current Borrowings: 8000000.00
CBT balance_sheet (annual, 2023-09-30) — Other Equity Adjustments: -362000000.00
CBT income_statement (annual, 2023-09-30) — Other Income Expense: -19000000.00
CBT balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 60000000.00
CBT balance_sheet (annual, 2023-09-30) — Other Inventories: 63000000.00
CBT cash_flow (annual, 2023-09-30) — Other Non Cash Items: 4000000.00
CBT balance_sheet (annual, 2023-09-30) — Other Non Current Assets: 172000000.00
CBT income_statement (annual, 2023-09-30) — Other Non Operating Income Expenses: -16000000.00
CBT balance_sheet (annual, 2023-09-30) — Other Properties: 228000000.00
CBT income_statement (annual, 2023-09-30) — Otherunder Preferred Stock Dividend: 8000000.00
CBT balance_sheet (annual, 2023-09-30) — Payables: 478000000.00
CBT balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 585000000.00
CBT cash_flow (annual, 2023-09-30) — Pension And Employee Benefit Expense: 0.00
CBT balance_sheet (annual, 2023-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 55000000.00
CBT balance_sheet (annual, 2023-09-30) — Preferred Stock: 0.00
CBT income_statement (annual, 2023-09-30) — Pretax Income: 451000000.00
CBT balance_sheet (annual, 2023-09-30) — Properties: 0.00
CBT cash_flow (annual, 2023-09-30) — Purchase Of Business: 0.00
CBT cash_flow (annual, 2023-09-30) — Purchase Of PPE: -244000000.00
CBT balance_sheet (annual, 2023-09-30) — Raw Materials: 148000000.00
CBT balance_sheet (annual, 2023-09-30) — Receivables: 695000000.00
CBT income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 3092000000.00
CBT income_statement (annual, 2023-09-30) — Reconciled Depreciation: 144000000.00
CBT cash_flow (annual, 2023-09-30) — Repayment Of Debt: -287000000.00
CBT cash_flow (annual, 2023-09-30) — Repurchase Of Capital Stock: -98000000.00
CBT income_statement (annual, 2023-09-30) — Research And Development: 57000000.00
CBT income_statement (annual, 2023-09-30) — Restructuring And Mergern Acquisition: 0.00
CBT balance_sheet (annual, 2023-09-30) — Retained Earnings: 1574000000.00
CBT cash_flow (annual, 2023-09-30) — Sale Of Business: 6000000.00
CBT cash_flow (annual, 2023-09-30) — Sale Of PPE: 7000000.00
CBT income_statement (annual, 2023-09-30) — Selling General And Administration: 253000000.00
CBT balance_sheet (annual, 2023-09-30) — Share Issued: 55379636.00
CBT cash_flow (annual, 2023-09-30) — Short Term Debt Issuance: 24000000.00
CBT cash_flow (annual, 2023-09-30) — Short Term Debt Payments: -197000000.00
CBT income_statement (annual, 2023-09-30) — Special Income Charges: -3000000.00
CBT cash_flow (annual, 2023-09-30) — Stock Based Compensation: 20000000.00
CBT balance_sheet (annual, 2023-09-30) — Stockholders Equity: 1264000000.00
CBT balance_sheet (annual, 2023-09-30) — Tangible Book Value: 1070000000.00
CBT income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: -630000.00
CBT income_statement (annual, 2023-09-30) — Tax Provision: -28000000.00
CBT income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.21
CBT balance_sheet (annual, 2023-09-30) — Total Assets: 3604000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Capitalization: 2358000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Debt: 1360000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 1407000000.00
CBT income_statement (annual, 2023-09-30) — Total Expenses: 3402000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 2197000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 1978000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 1375000000.00
CBT income_statement (annual, 2023-09-30) — Total Operating Income As Reported: 526000000.00
CBT balance_sheet (annual, 2023-09-30) — Total Tax Payable: 40000000.00
CBT income_statement (annual, 2023-09-30) — Total Unusual Items: -3000000.00
CBT income_statement (annual, 2023-09-30) — Total Unusual Items Excluding Goodwill: -3000000.00
CBT balance_sheet (annual, 2023-09-30) — Treasury Shares Number: 135832.00
CBT balance_sheet (annual, 2023-09-30) — Treasury Stock: 3000000.00
CBT balance_sheet (annual, 2023-09-30) — Working Capital: 804000000.00
CBT income_statement (annual, 2024-09-30) — +Operating Expense: 346000000.00
CBT income_statement (annual, 2024-09-30) — +Total Revenue: 3994000000.00
CBT balance_sheet (annual, 2024-09-30) — Accounts Payable: 495000000.00
CBT balance_sheet (annual, 2024-09-30) — Accounts Receivable: 733000000.00
CBT balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -2548000000.00
CBT balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 0.00
CBT balance_sheet (annual, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT income_statement (annual, 2024-09-30) — Average Dilution Earnings: 0.00
CBT income_statement (annual, 2024-09-30) — Basic Average Shares: 54297251.00
CBT income_statement (annual, 2024-09-30) — Basic EPS: 7.00
CBT cash_flow (annual, 2024-09-30) — Beginning Cash Position: 238000000.00
CBT balance_sheet (annual, 2024-09-30) — Buildings And Improvements: 601000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 601000000.00
CBT cash_flow (annual, 2024-09-30) — Capital Expenditure: -241000000.00
CBT balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 88000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 88000000.00
CBT balance_sheet (annual, 2024-09-30) — Capital Stock: 54000000.00
CBT balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 223000000.00
CBT balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 223000000.00
CBT cash_flow (annual, 2024-09-30) — Cash Dividends Paid: -93000000.00
CBT cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: -415000000.00
CBT cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: -235000000.00
CBT cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: 692000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Account Payable: 42000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Income Tax Payable: 3000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Inventory: 41000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Other Current Liabilities: 8000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Payable: 45000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: 45000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Prepaid Assets: 2000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Receivables: -26000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Tax Payable: 3000000.00
CBT cash_flow (annual, 2024-09-30) — Change In Working Capital: 70000000.00
CBT cash_flow (annual, 2024-09-30) — Changes In Cash: 42000000.00
CBT balance_sheet (annual, 2024-09-30) — Commercial Paper: 45000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Commercial Paper: 45000000.00
CBT balance_sheet (annual, 2024-09-30) — Common Stock: 54000000.00
CBT cash_flow (annual, 2024-09-30) — Common Stock Dividend Paid: -93000000.00
CBT balance_sheet (annual, 2024-09-30) — Common Stock Equity: 1425000000.00
CBT cash_flow (annual, 2024-09-30) — Common Stock Issuance: 20000000.00
CBT cash_flow (annual, 2024-09-30) — Common Stock Payments: -172000000.00
CBT balance_sheet (annual, 2024-09-30) — Construction In Progress: 392000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 392000000.00
CBT income_statement (annual, 2024-09-30) — Cost Of Revenue: 3034000000.00
CBT balance_sheet (annual, 2024-09-30) — Current Accrued Expenses: 107000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 107000000.00
CBT balance_sheet (annual, 2024-09-30) — Current Assets: 1605000000.00
CBT balance_sheet (annual, 2024-09-30) — Current Debt: 53000000.00
CBT balance_sheet (annual, 2024-09-30) — Current Debt And Capital Lease Obligation: 53000000.00
CBT balance_sheet (annual, 2024-09-30) — Current Liabilities: 772000000.00
CBT cash_flow (annual, 2024-09-30) — Deferred Income Tax: -37000000.00
CBT cash_flow (annual, 2024-09-30) — Deferred Tax: -37000000.00
CBT cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 151000000.00
CBT cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 151000000.00
CBT income_statement (annual, 2024-09-30) — Diluted Average Shares: 55700000.00
CBT income_statement (annual, 2024-09-30) — Diluted EPS: 6.72
CBT income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: 374000000.00
CBT cash_flow (annual, 2024-09-30) — Dividend Received Cfo: 2000000.00
CBT income_statement (annual, 2024-09-30) — EBIT: 610000000.00
CBT income_statement (annual, 2024-09-30) — EBITDA: 761000000.00
CBT income_statement (annual, 2024-09-30) — Earnings From Equity Interest Net Of Tax: 6000000.00
CBT cash_flow (annual, 2024-09-30) — Earnings Losses From Equity Investments: -6000000.00
CBT cash_flow (annual, 2024-09-30) — Effect Of Exchange Rate Changes: -57000000.00
CBT balance_sheet (annual, 2024-09-30) — Employee Benefits: 52000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Employee Benefits: 52000000.00
CBT cash_flow (annual, 2024-09-30) — End Cash Position: 223000000.00
CBT cash_flow (annual, 2024-09-30) — Financing Cash Flow: -415000000.00
CBT balance_sheet (annual, 2024-09-30) — Finished Goods: 333000000.00
CBT cash_flow (annual, 2024-09-30) — Free Cash Flow: 451000000.00
CBT cash_flow (annual, 2024-09-30) — Gain Loss On Sale Of Business: 0.00
CBT cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: 0.00
CBT cash_flow (annual, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
CBT cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
CBT income_statement (annual, 2024-09-30) — Gain On Sale Of Business: 0.00
CBT income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 0.00
CBT balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: -360000000.00
CBT balance_sheet (annual, 2024-09-30) — Goodwill: 133000000.00
CBT balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 186000000.00
CBT balance_sheet (annual, 2024-09-30) — Gross Accounts Receivable: 738000000.00
CBT balance_sheet (annual, 2024-09-30) — Gross PPE: 4082000000.00
CBT income_statement (annual, 2024-09-30) — Gross Profit: 960000000.00
CBT cash_flow (annual, 2024-09-30) — Income Tax Paid Supplemental Data: 136000000.00
CBT balance_sheet (annual, 2024-09-30) — Income Tax Payable: 43000000.00
CBT income_statement (annual, 2024-09-30) — Interest Expense: 81000000.00
CBT income_statement (annual, 2024-09-30) — Interest Expense Non Operating: 81000000.00
CBT income_statement (annual, 2024-09-30) — Interest Income: 32000000.00
CBT income_statement (annual, 2024-09-30) — Interest Income Non Operating: 32000000.00
CBT cash_flow (annual, 2024-09-30) — Interest Paid Supplemental Data: 82000000.00
CBT balance_sheet (annual, 2024-09-30) — Inventory: 552000000.00
CBT balance_sheet (annual, 2024-09-30) — Invested Capital: 2565000000.00
CBT cash_flow (annual, 2024-09-30) — Investing Cash Flow: -235000000.00
CBT balance_sheet (annual, 2024-09-30) — Investments And Advances: 23000000.00
CBT cash_flow (annual, 2024-09-30) — Issuance Of Capital Stock: 20000000.00
CBT cash_flow (annual, 2024-09-30) — Issuance Of Debt: 15000000.00
CBT balance_sheet (annual, 2024-09-30) — Land And Improvements: 74000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Land And Improvements: 74000000.00
CBT balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 88000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 88000000.00
CBT balance_sheet (annual, 2024-09-30) — Long Term Debt: 1087000000.00
CBT balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1175000000.00
CBT cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 15000000.00
CBT cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -30000000.00
CBT balance_sheet (annual, 2024-09-30) — Long Term Equity Investment: 23000000.00
CBT balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 2780000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 2780000000.00
CBT balance_sheet (annual, 2024-09-30) — Minority Interest: 165000000.00
CBT income_statement (annual, 2024-09-30) — Minority Interests: -44000000.00
CBT cash_flow (annual, 2024-09-30) — Net Business Purchase And Sale: 0.00
CBT cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
CBT cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: -152000000.00
CBT balance_sheet (annual, 2024-09-30) — Net Debt: 917000000.00
CBT income_statement (annual, 2024-09-30) — Net Income: 380000000.00
CBT income_statement (annual, 2024-09-30) — Net Income Common Stockholders: 374000000.00
CBT income_statement (annual, 2024-09-30) — Net Income Continuous Operations: 424000000.00
CBT income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 380000000.00
CBT income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 380000000.00
CBT cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: 424000000.00
CBT income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: 424000000.00
CBT income_statement (annual, 2024-09-30) — Net Interest Income: -49000000.00
CBT cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -143000000.00
CBT cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -15000000.00
CBT income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: -49000000.00
CBT cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -27000000.00
CBT cash_flow (annual, 2024-09-30) — Net Other Investing Changes: 6000000.00
CBT cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 3000000.00
CBT balance_sheet (annual, 2024-09-30) — Net PPE: 1534000000.00
CBT cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -241000000.00
CBT cash_flow (annual, 2024-09-30) — Net Short Term Debt Issuance: -128000000.00
CBT balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 1239000000.00
CBT balance_sheet (annual, 2024-09-30) — Non Current Accrued Expenses: 105000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Non Current Accrued Expenses: 105000000.00
CBT balance_sheet (annual, 2024-09-30) — Non Current Deferred Assets: 216000000.00
CBT balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 42000000.00
CBT balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Assets: 216000000.00
CBT balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Liabilities: 42000000.00
CBT income_statement (annual, 2024-09-30) — Normalized EBITDA: 761000000.00
CBT income_statement (annual, 2024-09-30) — Normalized Income: 380000000.00
CBT cash_flow (annual, 2024-09-30) — Operating Cash Flow: 692000000.00
CBT cash_flow (annual, 2024-09-30) — Operating Gains Losses: -6000000.00
CBT income_statement (annual, 2024-09-30) — Operating Income: 614000000.00
CBT income_statement (annual, 2024-09-30) — Operating Revenue: 3994000000.00
CBT balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 54297251.00
CBT balance_sheet (annual, 2024-09-30) — Other Current Assets: 97000000.00
CBT balance_sheet (annual, 2024-09-30) — Other Current Borrowings: 8000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 8000000.00
CBT balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: -360000000.00
CBT income_statement (annual, 2024-09-30) — Other Income Expense: -36000000.00
CBT income_statement (quarterly, 2024-09-30) — Other Income Expense: -3000000.00
CBT balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 53000000.00
CBT balance_sheet (annual, 2024-09-30) — Other Inventories: 69000000.00
CBT cash_flow (annual, 2024-09-30) — Other Non Cash Items: 63000000.00
CBT cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 3000000.00
CBT balance_sheet (annual, 2024-09-30) — Other Non Current Assets: 172000000.00
CBT income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: -36000000.00
CBT income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: -3000000.00
CBT balance_sheet (annual, 2024-09-30) — Other Properties: 235000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Other Properties: 235000000.00
CBT income_statement (annual, 2024-09-30) — Otherunder Preferred Stock Dividend: 6000000.00
CBT balance_sheet (annual, 2024-09-30) — Payables: 538000000.00
CBT balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 645000000.00
CBT cash_flow (annual, 2024-09-30) — Pension And Employee Benefit Expense: 0.00
CBT balance_sheet (annual, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 74000000.00
CBT balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 74000000.00
CBT balance_sheet (annual, 2024-09-30) — Preferred Stock: 0.00
CBT income_statement (annual, 2024-09-30) — Pretax Income: 529000000.00
CBT balance_sheet (annual, 2024-09-30) — Properties: 0.00
CBT balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
CBT cash_flow (annual, 2024-09-30) — Purchase Of Business: 0.00
CBT cash_flow (annual, 2024-09-30) — Purchase Of PPE: -241000000.00
CBT balance_sheet (annual, 2024-09-30) — Raw Materials: 150000000.00
CBT balance_sheet (annual, 2024-09-30) — Receivables: 733000000.00
CBT income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 3034000000.00
CBT income_statement (annual, 2024-09-30) — Reconciled Depreciation: 151000000.00
CBT cash_flow (annual, 2024-09-30) — Repayment Of Debt: -158000000.00
CBT cash_flow (annual, 2024-09-30) — Repurchase Of Capital Stock: -172000000.00
CBT income_statement (annual, 2024-09-30) — Research And Development: 63000000.00
CBT income_statement (annual, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CBT balance_sheet (annual, 2024-09-30) — Retained Earnings: 1734000000.00
CBT cash_flow (annual, 2024-09-30) — Sale Of Business: 0.00
CBT cash_flow (quarterly, 2024-09-30) — Sale Of Business: 0.00
CBT cash_flow (annual, 2024-09-30) — Sale Of PPE: 0.00
CBT cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
CBT income_statement (annual, 2024-09-30) — Selling General And Administration: 283000000.00
CBT balance_sheet (annual, 2024-09-30) — Share Issued: 54430316.00
CBT cash_flow (annual, 2024-09-30) — Short Term Debt Issuance: 0.00
CBT cash_flow (annual, 2024-09-30) — Short Term Debt Payments: -128000000.00
CBT cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: -4000000.00
CBT income_statement (annual, 2024-09-30) — Special Income Charges: 0.00
CBT income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
CBT cash_flow (annual, 2024-09-30) — Stock Based Compensation: 25000000.00
CBT balance_sheet (annual, 2024-09-30) — Stockholders Equity: 1425000000.00
CBT balance_sheet (annual, 2024-09-30) — Tangible Book Value: 1239000000.00
CBT income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (annual, 2024-09-30) — Tax Provision: 111000000.00
CBT income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.21
CBT balance_sheet (annual, 2024-09-30) — Total Assets: 3736000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Capitalization: 2512000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Debt: 1228000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 1590000000.00
CBT income_statement (annual, 2024-09-30) — Total Expenses: 3380000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 2146000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 2131000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1374000000.00
CBT income_statement (annual, 2024-09-30) — Total Operating Income As Reported: 614000000.00
CBT balance_sheet (annual, 2024-09-30) — Total Tax Payable: 43000000.00
CBT income_statement (annual, 2024-09-30) — Total Unusual Items: 0.00
CBT income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
CBT income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CBT income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CBT balance_sheet (annual, 2024-09-30) — Treasury Shares Number: 133065.00
CBT balance_sheet (annual, 2024-09-30) — Treasury Stock: 3000000.00
CBT balance_sheet (annual, 2024-09-30) — Working Capital: 833000000.00
CBT cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -27000000.00
CBT income_statement (quarterly, 2024-12-31) — Other Income Expense: 1000000.00
CBT balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 252000000.00
CBT income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 1000000.00
CBT cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -27000000.00
CBT income_statement (quarterly, 2025-03-31) — +Operating Expense: 79000000.00
CBT income_statement (quarterly, 2025-03-31) — +Total Revenue: 936000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 577000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 739000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2552000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
CBT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
CBT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 54000000.00
CBT income_statement (quarterly, 2025-03-31) — Basic EPS: 1.71
CBT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 183000000.00
CBT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -99000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 54000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 213000000.00
CBT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 213000000.00
CBT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -23000000.00
CBT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 17000000.00
CBT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -70000000.00
CBT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 73000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -28000000.00
CBT cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 2000000.00